Rhythm Pharmaceuticals buy Bank of America Co.
Start price
10.07.25
/
50%
€76.50
Target price
10.07.26
€80.90
Performance (%)
-13.73%
Price
31.03.26
€69.50
Summary
This prediction is currently active. The prediction for Rhythm Pharmaceuticals disappoints with a performance of -13.73%. This prediction currently runs until 10.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.000% | 0.000% |
| iShares Core DAX® | 1,60 % | -7,45 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % |
| iShares S&P 500 | -0,39 % | -2,34 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Bank of America Corporation from $73.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€120.90
17.03.27
17.03.27
-14.84%
31.03.26
31.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
07.04.25
07.04.25
€57.38
07.04.26
07.04.26
30.69%
31.03.26
31.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€20.80
01.08.23
01.08.23
-
01.08.24
01.08.24
97.12%
02.08.24
02.08.24